Isolated subcutaneous sarcoidosis presenting as multiple nodules: a rare case with diagnostic challenges Authors: Yoseph M. Habte, Binyam M. Habte, Makida M. Habte, Esimael M. Abdu, Amir M. Oumer, Shimelis A. Yimer Published: 2026 ABSTRACT Introduction and importance:Isolated subcutaneous sarcoidosis is an uncommon form of sarcoidosis, typically presenting as firm, painless nodules beneath clinically normal skin. Its rarity, especially in male patients or in atypical anatomical locations, can mimic malignant or infectious processes and cause significant diagnostic uncertainty. Recognizing this entity is important to prevent misdiagnosis and unnecessary interventions.Case presentation:A 51-year-old man presented with multiple progressively enlarging subcutaneous nodules over the scalp, face, trunk, and extremities for 1 year, without systemic symptoms. Imaging demonstrated well-defined subcutaneous soft-tissue lesions with no bony involvement. Fine-needle aspiration and core biopsy revealed non-caseating granulomas composed of fibrohistiocytic and multinucleated giant cells. Immunohistochemistry showed CD68 and S100 positivity, CD1a negativity, and a low Ki-67 index, confirming isolated subcutaneous sarcoidosis. A comprehensive evaluation found no systemic involvement at presentation.Clinical discussion:Subcutaneous sarcoidosis is rare and may closely resemble neoplastic or infectious conditions, particularly when presenting in unusual distributions or in male patients. Diagnosis relies on histopathologic confirmation of non-caseating granulomas, supported by immunohistochemical findings. Management should be individualized; options include observation for asymptomatic cases and topical or systemic corticosteroids for progressive or symptomatic lesions. Long-term monitoring is essential because systemic manifestations may develop later.Conclusion:This case highlights the importance of considering isolated subcutaneous sarcoidosis in the differential diagnosis of firm, painless nodules. Accurate diagnosis depends on histopathology and immunohistochemistry, and tailored management with ongoing follow-up is recommended. Reporting rare presentations broadens understanding of the clinical spectrum of sarcoidosis and ultimately supports timely, appropriate, and effective comprehensive patient care. Introduction Sarcoidosis is a multisystem granulomatous disorder of unknown etiology, characterized by non-caseating granulomas that primarily affect the lungs, lymphatic system, skin, and eyes, either individually or in combination[1–4]. The disease is thought to result from a dysregulated immune response to unidentified environmental antigens, leading to persistent T-cell- and macrophage-mediated granulomatous inflammation[4,5].HIGHLIGHTSIsolated subcutaneous sarcoidosis is an uncommon presentation that can occur in male patients and may involve multiple anatomical sites without systemic symptoms.The clinical appearance of firm, painless subcutaneous nodules can mimic malignancy, infection, or histiocytic disorders, making diagnosis challenging.Definitive diagnosis requires the integration of clinical, histopathological, and immunohistochemistry findings.Management should be individualized, ranging from observation to systemic corticosteroids for extensive or progressive lesions.Long-term follow-up is essential, as systemic sarcoidosis may develop even after initial isolated cutaneous involvement. HIGHLIGHTS Isolated subcutaneous sarcoidosis is an uncommon presentation that can occur in male patients and may involve multiple anatomical sites without systemic symptoms. Isolated subcutaneous sarcoidosis is an uncommon presentation that can occur in male patients and may involve multiple anatomical sites without systemic symptoms. The clinical appearance of firm, painless subcutaneous nodules can mimic malignancy, infection, or histiocytic disorders, making diagnosis challenging. The clinical appearance of firm, painless subcutaneous nodules can mimic malignancy, infection, or histiocytic disorders, making diagnosis challenging. Definitive diagnosis requires the integration of clinical, histopathological, and immunohistochemistry findings. Definitive diagnosis requires the integration of clinical, histopathological, and immunohistochemistry findings. Management should be individualized, ranging from observation to systemic corticosteroids for extensive or progressive lesions. Management should be individualized, ranging from observation to systemic corticosteroids for extensive or progressive lesions. Long-term follow-up is essential, as systemic sarcoidosis may develop even after initial isolated cutaneous involvement. Long-term follow-up is essential, as systemic sarcoidosis may develop even after initial isolated cutaneous involvement. Cutaneous involvement occurs in 25–30% of patients and may represent the initial manifestation of sarcoidosis[1,6]. Purely cutaneous sarcoidosis is uncommon, accounting for only 4–5% of cases[7]. Clinical presentations are diverse, including erythema nodosum, papules, plaques, infiltrated scars, lupus pernio, and, rarely, subcutaneous nodules (Darier–Roussy sarcoidosis)[1,2,6]. Subcutaneous sarcoidosis is among the rarest cutaneous forms, observed in 1.4–6% of patients with systemic disease[3,8]. Most cases occur in middle-aged women and manifest as multiple, firm, painless subcutaneous nodules beneath normal-appearing skin[9]. Rare presentations, including male patients or unusual anatomical distributions, can mimic infectious or neoplastic conditions, complicating diagnosis. Definitive diagnosis requires careful clinical evaluation, histopathological confirmation of non-caseating granulomas, and immunohistochemical exclusion of alternative granulomatous disorders. Here, we report a case of isolated subcutaneous sarcoidosis in a 51-year-old male, emphasizing the diagnostic challenges, the role of tissue confirmation, and the importance of individualized management and long-term follow-up. This case report has been written in compliance with the SCARE guidelines[10]. Case presentation A 51-year-old male presented with multiple, progressively enlarging subcutaneous swellings over the past year, affecting the skull, right cheek, trunk, and extremities. He reported bilateral knee joint pain without swelling or restriction of movement but denied systemic symptoms such as fever, night sweats, weight loss, cough, chest pain, dyspnea, abdominal pain, changes in bowel habits, or urinary complaints. There was no history of trauma, comorbidities, or prior similar lesions. On physical examination, the patient was alert, oriented, and hemodynamically stable. Examination revealed a deformed skull vault with a prominent right para-zygomatic subcutaneous swelling. Additional firm, non-tender nodules of varying sizes were present over the right forearm, cervical region, and trunk. No lymphadenopathy or hepatosplenomegaly was appreciated (Fig. 1). Cardiovascular, respiratory, and abdominal examinations were unremarkable. Figure 1.Extensive isolated subcutaneous sarcoidosis involving the face, scalp, trunk, and extremities. (A–C) Clinical images showing multiple subcutaneous nodules of varying sizes distributed over the neck, right, and left sides of the face and the posterior scalp (arrows). (D, F) Grossly visible numerous small subcutaneous nodules extensively involving the chest, abdomen, and back. (E) Subcutaneous swellings on the right and left forearm (arrows), appearing as firm, well-defined nodules. Extensive isolated subcutaneous sarcoidosis involving the face, scalp, trunk, and extremities. (A–C) Clinical images showing multiple subcutaneous nodules of varying sizes distributed over the neck, right, and left sides of the face and the posterior scalp (arrows). (D, F) Grossly visible numerous small subcutaneous nodules extensively involving the chest, abdomen, and back. (E) Subcutaneous swellings on the right and left forearm (arrows), appearing as firm, well-defined nodules. Laboratory investigations showed mild anemia (hemoglobin 11.5 g/dL and hematocrit 31.8%) and hypoalbuminemia (albumin 2.23 g/dL), with normal white blood cell and platelet counts. The erythrocyte sedimentation rate was 10 mm/h, and C-reactive protein was elevated at 17.92 mg/L. Liver and renal function tests were otherwise within normal limits. Serologies for hepatitis B, hepatitis C, and syphilis were negative. Urinalysis and thyroid function tests were unremarkable. Contrast-enhanced computed tomography (CT) of the head and neck revealed multiple well-defined, non-enhancing subcutaneous soft tissue lesions overlying the bilateral parietal, occipital, and high frontal scalp regions, without underlying bony involvement. Chest radiography and abdominal ultrasonography were unremarkable. Given the unusual distribution and appearance of the lesions, the differential diagnosis was broad, including neoplastic processes such as lymphoma or metastatic disease, infectious etiologies including mycobacterial or fungal infections, and rare histiocytic disorders. Fine-needle aspiration of multiple nodules revealed clusters of spindle and histiocytic cells with occasional cytoplasmic vacuolation, admixed lymphoid cells, and multinucleated giant cells. Acid-fast staining was negative. Core biopsies demonstrated a proliferation of spindle and histiocytic cells with vesicular nuclei arranged in a vague storiform pattern. There were admixed mononuclear inflammatory infiltrates and numerous epithelioid cell granulomas containing Langhans-type multinucleated giant cells. Mitoses were rare. Ziehl–Neelsen staining of histologic sections was repeatedly negative for acid-fast bacilli, and no fungal elements were identified. There were no features of cutaneous lymphoma. Overall, the findings were consistent with a proliferation of fibrohistiocytic cells with non-caseating granuloma formation and multinucleated giant cells (Fig. 2). Figure 2.Histopathology demonstrating non-caseating epitheloid cell granulomas with Langhans giant cells in the subcutaneous tissue. (A, C) Langhans giant cells (red arrows) within the subcutaneous tissue. (B) Langhans giant cell (red arrow) adjacent to a non-caseating epithelioid cell granuloma (white arrow). Hematoxylin and Eosin (H&E) stain, 400× magnification (all panels). Histopathology demonstrating non-caseating epitheloid cell granulomas with Langhans giant cells in the subcutaneous tissue. (A, C) Langhans giant cells (red arrows) within the subcutaneous tissue. (B) Langhans giant cell (red arrow) adjacent to a non-caseating epithelioid cell granuloma (white arrow). Hematoxylin and Eosin (H&E) stain, 400× magnification (all panels). Immunohistochemistry revealed CD68 and S100 positivity in histiocytic cells, CD1a negativity, and a low Ki-67 proliferative index (~1%). Lymphoid markers (CD3, CD45) highlighted admixed inflammatory cells. Special stains for fungal and mycobacterial organisms were negative. No cytologic atypia or mitotic activity was observed. The immunohistochemistry panel did not support a diagnosis of Langerhans or non-Langerhans cell histiocytic neoplasms, and the histologic features were not compatible with Rosai–Dorfman disease, despite the lesional cells being S100-positive and CD68-positive, with CD1a negativity – a pattern seen in Rosai–Dorfman disease. Integration of these clinical, histopathological, and immunohistochemical findings, together with the absence of systemic involvement, supported a diagnosis of isolated subcutaneous sarcoidosis. High-dose oral prednisolone (60 mg/day) was initiated as first-line therapy, followed by a gradual taper over several months according to clinical response, ultimately reaching a maintenance dose of 5 mg/day. Cotrimoxazole (trimethoprim–sulfamethoxazole 160/800 mg) was administered orally three times weekly as prophylaxis against Pneumocystis jirovecii pneumonia during corticosteroid therapy, and pantoprazole 40 mg was prescribed orally once daily for gastric protection. The patient was reviewed every 2 weeks during the initial phase of therapy and steroid tapering to monitor clinical response and disease progression. Progressive clinical improvement was noted, with significant reduction in the size and number of subcutaneous nodules over the course of treatment. At the most recent follow-up, no new lesions were observed, and the existing lesions had significantly regressed. Discussion Sarcoidosis is a multisystem inflammatory disorder of unknown etiology, characterized by the formation of non-caseating granulomas within affected organs. It most commonly involves the lungs, lymphatic system, skin, and eyes, either individually or in combination[1–4]. The pathogenesis is thought to involve a dysregulated immune response to unidentified environmental antigens, leading to persistent T-cell- and macrophage-mediated granulomatous inflammation[4,5]. Cutaneous involvement occurs in approximately 25–30% of patients and may represent the initial manifestation of sarcoidosis[1,6]. Purely cutaneous disease is uncommon, representing only 4–5% of cases[7]. Cutaneous sarcoidosis manifests in a variety of forms, including erythema nodosum, papules, nodules, plaques, infiltrated scars and tattoos, lupus pernio, and, less frequently, subcutaneous nodules known as Darier–Roussy sarcoidosis[1,2,6]. Subcutaneous sarcoidosis is among the rarest specific cutaneous forms, occurring in 1.4–6% of patients with systemic disease[3,8]. Most reported cases of subcutaneous sarcoidosis occur in white women during the fifth or sixth decades of life and present with multiple, firm, painless nodules beneath normal-appearing skin[9]. In contrast, our patient was a 51-year-old male with extensive nodular lesions distributed over the scalp, face, trunk, and extremities, but without systemic symptoms. This highlights that isolated subcutaneous sarcoidosis can occur in males and may mimic metastatic or infectious conditions, complicating the diagnostic process. Isolated subcutaneous sarcoidosis may occur with minimal or no systemic involvement[5,11,12], as observed in this patient. A case series of 19 patients by Lopez-Sundh et al described subcutaneous sarcoidosis with a mean age of 53 years and frequent but variable systemic involvement, particularly pulmonary disease (52.6%), while a subset had no significant extracutaneous manifestations. Most patients had favorable outcomes regardless of treatment, supporting the generally benign course of this entity and its possible association with limited or early systemic disease[11]. Similarly, Coakes et al reported a case of isolated subcutaneous sarcoidosis initially misdiagnosed as cellulitis, where systemic evaluation was negative. The lesion resolved completely following intralesional corticosteroid therapy with no recurrence over 4 years, highlighting both the diagnostic challenge and the potential effectiveness of localized treatment in isolated disease[12]. The broad differential diagnosis includes conditions that present with firm subcutaneous nodules and sparing of the superficial dermis, such as epidermal cysts, multiple lipomas, calcinosis, rheumatoid nodules, morphea, cutaneous metastases, neoplastic processes (lymphoma, metastases), infectious granulomatous diseases (mycobacterial or fungal infections), and rare histiocytic disorders[9]. Histopathology and immunohistochemistry are, therefore, essential for accurate diagnosis. Histologically, sarcoid granulomas are “naked,” containing few inflammatory cells[7]. In subcutaneous lesions, the infiltrate is predominantly lobular, with septal involvement reported in approximately 75% of cases[8]. In this case, core biopsies revealed non-caseating granulomas composed of fibrohistiocytic and multinucleated giant cells, with CD68 and S100 positivity, CD1a negativity, low Ki-67 proliferative index, and negative fungal and mycobacterial stains, confirming sarcoidosis. Definitive diagnosis relies on three criteria: compatible clinical presentation, histologic identification of non-necrotizing granulomas, and exclusion of alternative causes of granulomatous disease[4]. All three were satisfied in this patient. Although isolated subcutaneous sarcoidosis often appears near the onset of systemic disease, it can remain localized. Long-term follow-up is recommended, as systemic involvement may develop later[5,8]. Management should be individualized. Systemic corticosteroids are the first-line therapy for symptomatic, progressive, or organ-threatening sarcoidosis, while immunosuppressive agents may be considered for refractory cases[1,2,5]. For isolated or asymptomatic cutaneous lesions, observation or conservative therapy is appropriate, given the potential for spontaneous resolution[2]. In this patient, although there was no evidence of systemic involvement, the extensive subcutaneous lesions warranted systemic therapy with oral prednisolone. Pantoprazole was co-administered for gastric protection, and cotrimoxazole prophylaxis was initiated during corticosteroid therapy. Close follow-up was arranged to monitor treatment response and detect any potential progression or development of systemic disease. This case illustrates the diagnostic challenge posed by rare presentations of sarcoidosis, particularly subcutaneous sarcoidosis, which can mimic both neoplastic and infectious conditions. It underscores the importance of tissue biopsy and immunohistochemistry for a definitive diagnosis, the necessity of ongoing systemic evaluation, and the value of individualized management strategies in such rare presentations. Conclusion Isolated subcutaneous sarcoidosis is a rare and diagnostically challenging variant, particularly when the clinical presentation deviates from classic demographics or mimics malignancy or infection. Accurate diagnosis requires a high index of suspicion, careful clinical evaluation, and confirmation through histopathology and immunohistochemistry to exclude alternative granulomatous disorders. This case underscores the importance of considering isolated subcutaneous sarcoidosis in the differential diagnosis of firm, painless subcutaneous nodules, even in male patients without systemic symptoms. Management should be individualized, ranging from observation in asymptomatic cases to systemic or topical corticosteroids for progressive or symptomatic lesions. Long-term follow-up is essential, as systemic involvement may develop subsequently. Reporting rare presentations such as this contributes to a better understanding of the clinical spectrum of sarcoidosis and facilitates timely, accurate diagnosis and management.